205 related articles for article (PubMed ID: 29778180)
1. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
[TBL] [Abstract][Full Text] [Related]
2. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
[TBL] [Abstract][Full Text] [Related]
4. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
5. Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against
Zhang L; Zhou Z; Gu X; Huang S; Shen X; Ding H
Front Vet Sci; 2020; 7():448. PubMed ID: 32851028
[TBL] [Abstract][Full Text] [Related]
6. Kill Rate and Evaluation of
Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine.
Vanni M; Merenda M; Barigazzi G; Garbarino C; Luppi A; Tognetti R; Intorre L
Vet Microbiol; 2012 Apr; 156(1-2):172-7. PubMed ID: 22104584
[TBL] [Abstract][Full Text] [Related]
8. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.
Tanigawa M; Sawada T
J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):436-42. PubMed ID: 14633197
[TBL] [Abstract][Full Text] [Related]
9. Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.
Wang H; Liao C; Ding K; Zhang L; Wang L
BMC Vet Res; 2024 Jun; 20(1):241. PubMed ID: 38831324
[TBL] [Abstract][Full Text] [Related]
10. Lung microdialysis and
Chen Y; Li M; Su D; Xiong S; Feng Y; Deng Q; Ding H
Front Vet Sci; 2024; 11():1390336. PubMed ID: 38596468
[TBL] [Abstract][Full Text] [Related]
11. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia.
Asawa T; Kobayashi H; Mitani K; Ito N; Morozumi T
J Vet Med Sci; 1995 Aug; 57(4):757-9. PubMed ID: 8519914
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures.
Kim B; Min K; Choi C; Cho WS; Cheon DS; Kwon D; Kim J; Chae C
J Vet Med Sci; 2001 Mar; 63(3):341-2. PubMed ID: 11307940
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity of cefquinome against Riemerella anatipestifer using the pericarditis model in the duck.
Qiu Z; Cao C; Qu Y; Lu Y; Sun M; Zhang Y; Zhong J; Zeng Z
J Vet Pharmacol Ther; 2016 Jun; 39(3):299-304. PubMed ID: 26560807
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
Wang J; Shan Q; Ding H; Liang C; Zeng Z
Antimicrob Agents Chemother; 2014 Jun; 58(6):3008-12. PubMed ID: 24614373
[TBL] [Abstract][Full Text] [Related]
16. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic adaptation and biofilm formation of Actinobacillus pleuropneumoniae field isolates from the upper and lower respiratory tract of swine with respiratory disease.
Aper D; Frömbling J; Bağcıoğlu M; Ehling-Schulz M; Hennig-Pauka I
Vet Microbiol; 2020 Jan; 240():108532. PubMed ID: 31902502
[TBL] [Abstract][Full Text] [Related]
18. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
Dorey L; Hobson S; Lees P
Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Pelligand L; Cheng Z; Lees P
PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against
Yao L; Yang L; Ling Y; Wei Y; Shen X; Ding H
Front Vet Sci; 2022; 9():822432. PubMed ID: 35419449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
